Skip to content

Alexza Pharmaceuticals Inc.

Delisted

CIK 1344413fmd_1W03MX7JTEW1ZMT0JJ8C8HX1C9Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2001 to Mar 31, 2016, 33 periods

Income Statement · Annual · Millions · USD
Line itemFY2006FY2007FY2008FY2009FY2010FY2011FY2012FY2013FY2014FY2015
Total revenues–––1043644865
Rental revenue––––120000
Cost of revenue––––––0111621
Gross profit––––––437(10)(16)
Research and development–––40342822191412
Operating income–––(48)(5)(34)(29)2(37)(40)
Interest expense–––0221178
Income tax expense––––––0000
Net income(44)(56)(77)(104)(1)(41)(28)(40)(37)(21)
Alexza Pharmaceuticals Inc. financial statements · FinancialMD